US Stock MarketDetailed Quotes
SHPH Shuttle Pharmaceuticals
- 0.850
- -0.020-2.30%
Close Nov 27 16:00 ET
- 0.850
- 0.000-0.01%
Post 18:28 ET
3.12MMarket Cap-200P/E (TTM)
0.853High0.809Low64.23KVolume0.809Open0.870Pre Close53.40KTurnover2.28%Turnover RatioLossP/E (Static)3.66MShares4.94652wk High-2.37P/B2.40MFloat Cap0.80952wk Low--Dividend TTM2.82MShs Float1010.080Historical High--Div YieldTTM5.08%Amplitude0.809Historical Low0.831Avg Price1Lot Size
Shuttle Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -30.21%-2M | 14.99%-1.4M | 7.39%-1.24M | -109.31%-5.58M | -67.05%-1.06M | -46.11%-1.53M | -363.13%-1.65M | -114.21%-1.34M | -787.81%-2.67M | -370.45%-635.82K |
| Net income from continuing operations | -111.08%-3.78M | 7.01%-2.03M | -77.52%-1.73M | -31.96%-6.59M | 39.65%-1.64M | -79.56%-1.79M | -265.72%-2.18M | -43.01%-975.1K | -333.64%-5M | -492.21%-2.72M |
| Operating gains losses | 205.00%419.47K | 608.60%104.09K | 89.32%-130.58K | -167.78%-1.74M | -103.71%-101.54K | -254.16%-399.49K | -135.03%-20.47K | -985.35%-1.22M | 501.04%2.57M | 599.89%2.74M |
| Depreciation and amortization | -57.32%793 | -35.09%962 | 28.49%1.91K | 14.05%6.81K | 33.27%1.98K | 17.22%1.86K | 2.28%1.48K | 2.62%1.49K | -90.18%5.97K | -90.91%1.49K |
| Other non cash items | -52.17%283.32K | -49.79%386.51K | -20.96%464.29K | 10,046.43%2.42M | 178.88%468.33K | 103.63%592.4K | 416.78%769.81K | 353.38%587.44K | -817.32%-24.31K | ---593.75K |
| Change In working capital | 2,733.11%993.68K | 114.27%41.19K | -85.31%44.17K | 147.67%220.63K | 221.92%173.47K | 113.73%35.07K | -116.14%-288.57K | 335.52%300.66K | -189.14%-462.79K | -82.61%53.89K |
| -Change in receivables | 231.67%7.22K | 6,390.41%4.74K | 141.82%2.94K | ---14.9K | -141.42%-2.47K | 7.88%-5.49K | --73 | ---7.02K | --0 | --5.95K |
| -Change in prepaid assets | 140.02%36.48K | -107.91%-9.88K | 64.46%-15.17K | 129.87%46.68K | 2,689.92%55.63K | 39.08%-91.16K | 1,659.45%124.89K | -171.08%-42.69K | -2,126.22%-156.28K | -18.01%1.99K |
| -Change in payables and accrued expense | 676.77%950.19K | 110.91%46.09K | -84.44%55.94K | 155.31%166.38K | 124.96%107.18K | 224.07%122.33K | -203.41%-422.6K | 425.07%359.47K | -183.92%-300.82K | -85.24%47.65K |
| -Change in other current assets | ---- | ---- | --0 | --6.48K | ---- | ---- | ---- | ---7.21K | --0 | ---- |
| -Change in other working capital | -102.18%-205 | -87.29%237 | 124.60%466 | 381.06%16K | 489.16%6.64K | 806.40%9.39K | --1.86K | ---1.89K | ---5.69K | ---1.71K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -30.21%-2M | 14.99%-1.4M | 7.39%-1.24M | -109.31%-5.58M | -67.05%-1.06M | -46.11%-1.53M | -363.13%-1.65M | -114.21%-1.34M | -787.81%-2.67M | -370.45%-635.82K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 6,506.87%1.66M | 1,743.79%1.16M | 103.43%101.3K | -2.83M | 87.04K | -25.86K | 62.8K | -2.95M | 0 | 0 |
| Net PPE purchase and sale | ---- | ---- | ---- | ---19.05K | --0 | ---- | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | 24,428.02%1.66M | 1,743.79%1.16M | 103.43%101.3K | ---2.81M | --87.04K | ---6.81K | --62.8K | ---2.95M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 6,506.87%1.66M | 1,743.79%1.16M | 103.43%101.3K | ---2.83M | --87.04K | ---25.86K | --62.8K | ---2.95M | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -196.79K | -231.59%-461.67K | -101.31%-40K | -75.71%2.57M | -396.48%-334.44K | 0 | -139.23K | 478.97%3.04M | 1,437.78%10.58M | -113.61%-67.36K |
| Net issuance payments of debt | ---95.14K | -260.32%-501.67K | --0 | 385.27%2.92M | ---334.44K | --0 | ---139.23K | 544.60%3.39M | -12.68%600.72K | --0 |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --10M | ---50K |
| Cash dividends paid | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | -1,886.98%-345K | --0 | --0 | --0 | ---345K | ---17.36K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---196.79K | -231.59%-461.67K | -101.31%-40K | -75.71%2.57M | -396.48%-334.44K | --0 | ---139.23K | 478.97%3.04M | 1,437.78%10.58M | -113.61%-67.36K |
| Net cash flow | ||||||||||
| Beginning cash position | -87.23%695.59K | -80.49%1.4M | -69.39%2.58M | 1,567.60%8.42M | -57.39%3.89M | 10,699.19%5.45M | 1,666.45%7.17M | 1,567.60%8.42M | 330.85%504.75K | 6,191.01%9.12M |
| Current changes in cash | 65.47%-538.94K | 59.18%-703.03K | 5.62%-1.18M | -173.82%-5.84M | -86.24%-1.31M | -117.21%-1.56M | -384.63%-1.72M | -1,161.92%-1.25M | 1,941.42%7.91M | -295.45%-703.19K |
| End cash Position | -95.97%156.66K | -87.23%695.59K | -80.49%1.4M | -69.39%2.58M | -69.39%2.58M | -57.39%3.89M | 10,699.19%5.45M | 1,666.45%7.17M | 1,567.60%8.42M | 1,567.60%8.42M |
| Free cash flow | -28.61%-2M | 14.99%-1.4M | 7.39%-1.24M | -110.03%-5.6M | -67.05%-1.06M | -47.92%-1.55M | -363.13%-1.65M | -114.21%-1.34M | -787.81%-2.67M | -370.45%-635.82K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data